Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lafeuillade

Showing results (11-20 of 94) with videos related to

Pageof 10
Sort By:
The Journal of Infectious Diseases|September 18, 1997
Human immunodeficiency virus type 1 dynamics in different lymphoid tissue compartmentsA Lafeuillade, C Poggi, C Tamalet, et al.
The American Journal of Medicine|April 1, 1992
Maintenance itraconazole for visceral leishmaniasis in HIV infectionA Lafeuillade, P Chaffanjon, E Delbeke, et al.
HIV Medicine|December 12, 2001
Phenotypic and genotypic resistance to nucleoside reverse transcriptase inhibitors in HIV-1 clinical isolatesA Lafeuillade, C Poggi, G Hittinger, et al.
The Journal of Infectious Diseases|June 1, 1996
Relationship between immune complex-dissociated p24 antigen and human immunodeficiency virus type 1 RNA titers in plasmaA Lafeuillade, C Poggi, C Tamalet, et al.
Journal of Viral Hepatitis|September 29, 2009
Response to Madejon et al.: are HIV-infected patients at risk of HEV infection?C Renou, A Lafeuillade, N Pavio, et al.
Lancet (London, England)|March 9, 1991
Optic neuritis associated with dideoxyinosineA Lafeuillade, L Aubert, P Chaffanjon, et al.
Infection|November 1, 1996
Quantitative molecular monitoring of HIV-1 RNA during antiretroviral therapyA Lafeuillade, C Poggi, P Pellegrino, et al.
Infection|May 1, 1996
Serum HIV-1 RNA load to predict CD4+ T-cell depletion in asymptomatic patientsA Lafeuillade, C Poggi, P Pellegrino, et al.
AIDS (London, England)|December 1, 1995
Virological analysis of primary HIV-1 infection with rapid CD4 depletionA Lafeuillade, C Tamalet, P de Micco, et al.
Infection|October 23, 1997
HHV-8 in PBMC and Kaposi's sarcoma activityC Poggi, A Lafeuillade, N Profizi, et al.
Pageof 10

Showing results (11-20 of 94) with videos related to

Sort By:
Pageof 10
The Journal of Infectious Diseases|September 18, 1997
Human immunodeficiency virus type 1 dynamics in different lymphoid tissue compartmentsA Lafeuillade, C Poggi, C Tamalet, et al.
The American Journal of Medicine|April 1, 1992
Maintenance itraconazole for visceral leishmaniasis in HIV infectionA Lafeuillade, P Chaffanjon, E Delbeke, et al.
HIV Medicine|December 12, 2001
Phenotypic and genotypic resistance to nucleoside reverse transcriptase inhibitors in HIV-1 clinical isolatesA Lafeuillade, C Poggi, G Hittinger, et al.
The Journal of Infectious Diseases|June 1, 1996
Relationship between immune complex-dissociated p24 antigen and human immunodeficiency virus type 1 RNA titers in plasmaA Lafeuillade, C Poggi, C Tamalet, et al.
Journal of Viral Hepatitis|September 29, 2009
Response to Madejon et al.: are HIV-infected patients at risk of HEV infection?C Renou, A Lafeuillade, N Pavio, et al.
Lancet (London, England)|March 9, 1991
Optic neuritis associated with dideoxyinosineA Lafeuillade, L Aubert, P Chaffanjon, et al.
Infection|November 1, 1996
Quantitative molecular monitoring of HIV-1 RNA during antiretroviral therapyA Lafeuillade, C Poggi, P Pellegrino, et al.
Infection|May 1, 1996
Serum HIV-1 RNA load to predict CD4+ T-cell depletion in asymptomatic patientsA Lafeuillade, C Poggi, P Pellegrino, et al.
AIDS (London, England)|December 1, 1995
Virological analysis of primary HIV-1 infection with rapid CD4 depletionA Lafeuillade, C Tamalet, P de Micco, et al.
Infection|October 23, 1997
HHV-8 in PBMC and Kaposi's sarcoma activityC Poggi, A Lafeuillade, N Profizi, et al.
Pageof 10